Loba Biotech Gmbh, based in Austria, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NAPHAZOLINE HYDROCHLORIDE, with a corresponding US DMF Number 10667.
Remarkably, this DMF maintains an Active status since its submission on January 12, 1994, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 02, 2013, and payment made on June 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II